Walleye Trading
RDY icon

Walleye Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Walleye Trading’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,000
Closed -$352K – 4821
2024
Q1 		$352K Buy
+24,000
New +$350K ﹤0.01% 3058
2023
Q3 		– Sell
-33,500
Closed -$423K – 5287
2023
Q2 		$423K Hold
33,500
– – ﹤0.01% 2874
2023
Q1 		$381K Buy
+33,500
New +$362K ﹤0.01% 3011
2022
Q2 		– Sell
-25,000
Closed -$279K – 5578
2022
Q1 		$279K Buy
+25,000
New +$283K ﹤0.01% 3496
2021
Q4 		– Sell
-71,000
Closed -$925K – 5778
2021
Q3 		$925K Buy
+71,000
New +$946K ﹤0.01% 2286
2021
Q2 		– Sell
-55,000
Closed -$675K – 5477
2021
Q1 		$675K Buy
55,000
+39,500
+255% +$507K ﹤0.01% 2308
2020
Q4 		$221K Sell
15,500
-46,500
-75% -$626K ﹤0.01% 3428
2020
Q3 		$863K Buy
62,000
+51,500
+490% +$614K ﹤0.01% 1772
2020
Q2 		$111K Buy
+10,500
New +$107K ﹤0.01% 3453

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Walleye Trading's RDY Position: Q4 2018 in Review

Walleye Trading sold out of Dr. Reddy's Laboratories (RDY) in Q4 2018, closing a stake of 20 shares.

Walleye Trading first reported a position in RDY in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 146 funds tracked by Wall St. Rank hold RDY as of Q4 2018.

  • Walleye Trading reported no remaining Dr. Reddy's Laboratories position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 20 Dr. Reddy's Laboratories shares in Q4 2018.
  • Walleye Trading first reported a position in Dr. Reddy's Laboratories in Q3 2018 and held it in 1 quarter.
  • Walleye Trading's Dr. Reddy's Laboratories position peaked at $0 in Q3 2018.
  • 146 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.